Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | London | GBP | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GSK | NYSE | USD | Real-time | |
GLAXF | OTC Markets | USD | Delayed | |
GSKN | Mexico | MXN | Delayed | |
GS70y | Frankfurt | EUR | Delayed | |
GS71 | Frankfurt | EUR | Delayed | |
GS71 | TradeGate | EUR | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
Period Ending: | 2022 31/12 |
2022 30/09 |
2022 30/06 |
2022 31/03 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 7376 | 7829 | 6929 | 7190 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 2186 | 2386 | 2145 | 2690 | ||||||||||||||||||||||||||||||
Gross Profit | 5190 | 5443 | 4784 | 4500 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 5961 | 5468 | 5220 | 5482 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 1415 | 2361 | 1709 | 1708 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | 471 | - | - | - | ||||||||||||||||||||||||||||||
Other, Net | -682 | 1349 | 813 | -386 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 1626 | 1012 | 896 | 2094 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 1 | 233 | 150 | 323 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 1625 | 779 | 746 | 1771 | ||||||||||||||||||||||||||||||
Minority Interest | -502 | -436 | 6266 | 6451 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 1500 | 759 | 706 | 1496 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | 501 | 9556 | 132 | 306 | ||||||||||||||||||||||||||||||
Net Income | 2001 | 10315 | 838 | 1802 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | -501 | -9556 | -132 | -306 | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 1500 | 759 | 706 | 1496 | ||||||||||||||||||||||||||||||
Dilution Adjustment | 500.72 | 9554.63 | 130.86 | 305.1 | ||||||||||||||||||||||||||||||
Diluted Net Income | 1500.28 | 760.37 | 707.14 | 1496.9 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 4091 | 4088 | 4064 | 4054 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 0.367 | 0.186 | 0.174 | 0.369 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | 0.138 | 0.138 | 0.162 | 0.175 | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 0.148 | 0.329 | 0.225 | 0.165 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review